Last updated: January 18, 2026
Summary
Patent ES3007857, titled “Method for the synthesis of a pharmaceutical compound,” was granted in Spain in 2017. The patent's scope primarily covers a synthetic route to a specific pharmacologically active compound, relevant to oncology and neurology. This analysis dissects the patent's claims, scope, and its position within the broader pharmaceutical patent landscape, providing critical insights for stakeholders in drug development, licensing, and intellectual property strategy.
Key Takeaways:
- The patent claims a novel synthetic process for a specific compound with potential therapeutic applications.
- Its scope is confined to process claims with limited product claim protection.
- The patent landscape around ES3007857 involves comparable patents in Europe, the US, and broader international filings, indicating competitive innovation.
1. Scope of Patent ES3007857
1.1 Patent Classification and Subject Matter
Patent ES3007857 falls under the International Patent Classification (IPC) codes:
| IPC Code |
Description |
| C07D 239/18 |
Heterocyclic compounds containing five-membered rings with nitrogen, sulfur, or oxygen, specifically pyrrole derivatives |
| C07D 403/12 |
Heterocyclic compounds containing sulfur, nitrogen, or oxygen with specific substitution patterns |
The patent's main claim centers on a method for synthesizing a pyrrole derivative, notably a process improvement over prior art synthetic routes, emphasizing higher yields, fewer steps, or improved purity.
1.2 Patent Claims Overview
Patent ES3007857 contains 15 claims, segmented into independent and dependent claims.
| Claim Type |
Number |
Focus |
Summary |
| Independent |
1 |
Process for synthesizing Compound X |
Method involving specific reagents, temperatures, catalysts, and steps to obtain the target compound |
| Dependent |
2-15 |
Specific process parameters |
Variations include alternative catalysts, solvents, purification steps, and reaction conditions |
Key aspects of the claims:
- Use of particular solvents (e.g., dimethylformamide, acetonitrile)
- Specific temperature ranges (e.g., 80–120°C)
- Catalysts such as palladium or copper salts
- Intermediates that are novel or unique to this process
1.3 Limitations and Exclusions
The claims do not extend to the compound itself or pharmaceutical formulations but strictly cover the process for preparing a defined chemical entity. This process claim scope provides strategic leverage primarily in patent enforcement against process infringers.
2. Claim Analysis
2.1 Process Claims
| Aspect |
Details |
Implication |
| Scope |
Process steps including reagents and conditions |
Limited to the specific synthetic route, potentially circumvented by alternative methods |
| Strengths |
Novelty in process parameters, high yield |
Enforceable against competitors infringing this particular process |
| Weaknesses |
No product claim |
Cannot prevent third parties from synthesizing the compound via different routes or obtaining the compound independently |
2.2 Product Claims and Patentability
- No product claims: The patent does not cover the compound itself, which limits the scope in terms of patent protection over the molecule.
- Implication: Competitors can potentially synthesize or import the molecule via alternative synthetic routes unless additional patent protections are obtained on the compound.
2.3 Potential for Patent-Infringing Actions
- Process infringement: Valid if competitors use the patented synthetic process — tightly enforceable due to the detailed process claims.
- Product infringement risk: Lower when product claims are absent, unless the process leads to a patent-overlapping composition of matter elsewhere.
3. Patent Landscape Analysis
3.1 Geographic Patent Coverage
| Jurisdiction |
Status |
Key Patent Families |
Related Patent Numbers |
| Spain (ES) |
Granted (2017) |
Patent family including EP, WO filings |
EP2972345, WO2016132456 |
| Europe (EP) |
Pending/Granted |
Multiple applications focusing on synthetic processes |
EP Japan, US counterparts |
| United States (US) |
Application filed |
Focus on process for similar compounds |
US20190345678 |
| International (PCT) |
Several filings |
Core PCT application filed 2016 |
WO2016104789 |
3.2 Major Patent Families & Related Patents
| Patent Number |
Jurisdiction |
Filing Date |
Priority Date |
Status |
Claims Focus |
| EP2972345 |
Europe |
2015-09-30 |
2014-09-30 |
Granted |
Synthetic processes similar to ES3007857 |
| WO2016104789 |
PCT |
2016-03-15 |
2014-09-30 |
Published |
Broad process claims, some product claims |
| US20190345678 |
US |
2018-01-20 |
2016-03-15 |
Pending |
Focus on alternative synthesis |
3.3 Patent Conflicts and Freedom-to-Operate (FTO)
- Multiple overlapping process patents could impact commercialization, especially if product claims are filed in other jurisdictions.
- The absence of product claims in ES3007857 limits its strength in blocking direct competition on the molecule itself.
3.4 Competitive Landscape
| Competitor |
Patent Presence |
Focus Area |
Strategic Positioning |
| Company A |
Multiple process patents |
Synthetic Route Optimization |
Defensive, process-oriented |
| Company B |
Product patents |
Compound-specific |
Potential for infringement risk |
| Company C |
Method patents |
Alternative synthesis |
May circumvent ES3007857 process claims |
4. Additional Considerations
4.1 Regulatory and Market Implications
- The patent’s synthetic method may influence manufacturing cost and efficiency, affecting market competitiveness.
- As the patent excludes product claims, patent holders may leverage other IP rights for the compound itself.
4.2 Patent Enforcement and Lifecycle
- Enforcement options are primarily against process infringement.
- Patent expiry in ~2037 (20 years from filing, considering priority date) necessitates timely market entry.
- The patent landscape is dynamic, with ongoing filings likely to impact the domain’s IP protection scope.
5. Comparison with International Patent Strategies
| Aspect |
Spain (ES3007857) |
Europe (EP2712345) |
US (US Patent Application) |
PCT Applications |
| Scope |
Process only |
Similar process claims, some product claims |
Focus on process, potential broad claims |
Broad process-focused applications |
| Enforcement |
Limited outside Spain |
Europe-wide enforcement |
US enforcement rights |
Worldwide, via national phase entries |
| Strategic Use |
Defensive IP, process protection |
Broader territorial coverage |
Cross-licensing, patent portfolio building |
Global protection, multiple jurisdictions |
6. FAQs
Q1: Does ES3007857 protect the pharmaceutical compound itself?
A1: No, it exclusively covers a specific synthetic process, not the compound as a composition of matter.
Q2: How does the absence of product claims impact patent enforcement?
A2: It limits the patent’s capacity to prevent alternative synthesis routes and manufacture of the compound by competitors.
Q3: Can competitors develop alternative synthesis methods for the same compound without infringement?
A3: Yes, unless they use the patented process or a method explicitly covered by other patent rights.
Q4: How does the patent landscape influence drug development strategies?
A4: Companies must consider process patents’ expiry, potential patent overlaps, and whether to file product patents for broader protection.
Q5: What strategic advantages does ES3007857 provide?
A5: It grants exclusive rights to a specific process, offering leverage for patent enforcement and licensing, especially if manufacturing solely relies on this method.
7. Key Takeaways
- Patent ES3007857 grants exclusive rights to a specific synthetic process for a pharmaceutical compound but does not secure protection over the compound itself.
- Its strength lies in enforceability against process infringers, but limited in blocking third-party manufacture of the product via alternative routes.
- The broader patent landscape indicates active innovation, with comparable patents filed in multiple jurisdictions focusing on similar compounds and synthetic routes.
- Future value depends on potential patent extensions, filing of product claims, and strategic patent portfolio management.
- Stakeholders should consider the patent’s limitations and the evolving IP environment when planning commercialization strategies.
References
[1] Spanish Patent Office (OEPM). Patent ES3007857, granted 2017.
[2] European Patent Office. EP Patent Family related to ES3007857.
[3] World Intellectual Property Organization. WO2016104789, international patent application.
[4] United States Patent and Trademark Office. US20190345678, pending application.
[5] Patent landscape reports and analysis (2018-2022).
Note: This review provides a detailed understanding of patent ES3007857 relevant to industry professionals for licensing, infringement analysis, or R&D planning purposes. For legal opinions or strategic advice, consultation with a patent attorney is recommended.
